| CPC G16H 50/20 (2018.01) [A61B 5/0042 (2013.01); A61B 5/0046 (2013.01); A61B 5/0205 (2013.01); A61B 5/021 (2013.01); A61B 5/055 (2013.01); A61B 5/14532 (2013.01); A61B 5/14542 (2013.01); A61B 5/332 (2021.01); A61B 5/6801 (2013.01); A61B 5/742 (2013.01); A61B 5/749 (2013.01); A61G 3/001 (2013.01); G06T 7/0014 (2013.01); G16H 10/20 (2018.01); G16H 10/60 (2018.01); G16H 20/40 (2018.01); G16H 50/30 (2018.01); G16H 70/20 (2018.01); G16H 70/40 (2018.01); A61B 50/36 (2016.02); A61B 2560/0493 (2013.01); A61F 17/00 (2013.01); A61G 10/00 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/30016 (2013.01); G06T 2207/30101 (2013.01)] | 7 Claims |
|
1. A regionally integrated emergency stroke unit, comprising: an information interaction area, an imaging examination area, and a thrombolytic therapy area, wherein
a doctor workstation, a comprehensive information surveillance monitor, and a process support artificial intelligence (AI) assistant are set in the information interaction area; the doctor workstation comprises a computer, a file rack, and a folding table; the computer is configured for a doctor to enter information; the file rack is configured to place a document; the folding table is configured to temporarily place and store a medical device and a document; the comprehensive information surveillance monitor is configured to display basic information, an arrival time at a hospital, an arrival time at a clinic, and vital signs of a patient; and the process support AI assistant is configured to perform, via voice interaction or touchscreen keying interaction, automatic inquiry and auxiliary nervous system scale scoring, and further provide real-time retrieval support for a knowledge base and a clinical guideline;
an intelligent interaction module is disposed in the process support AI assistant; and the intelligent interaction module is configured to perform, based on an emergency structured record, structured questioning on key medical information about the patient comprising a time of onset, an onset symptom, a concomitant symptom, a past medical history, and an allergy history, perform voice recognition on an answer of the patient and/or a family of the patient, and perform structured entry of the key medical information;
the intelligent interaction module is further configured to score via voice interaction or touchscreen keying interaction with the patient and/or the family of the patient based on the auxiliary nervous system scale comprising a National Institute of Health stroke scale (NIHSS), an age, blood pressure, clinical features, duration, diabetes (ABCD2) scale, and a pre-morbid modified rankin scale (mRS), to obtain a scale score result;
a large language model is further stored in the intelligent interaction module; the large language model comprises a knowledge base related to clinical diagnosis and therapy of a stroke, comprising a clinical scale, a guideline for acute cerebral infarction, a guideline for secondary prevention of cerebral infarction, a guideline for diagnosis and therapy of cerebral hemorrhage, a guideline for clinical diagnosis and therapy of subarachnoid hemorrhage; and in a process of diagnosis and therapy, retrieval of the knowledge base and the clinical guideline is implemented via voice interaction or touchscreen keying interaction with the doctor;
a test device, a first television display, a movable low-field magnetic resonance imager, and an AI-assisted decision-making system are set in the imaging examination area; the test device is configured to perform electrocardiogram examination and pharmacogenetic testing, and monitor oxygen saturation, a blood pressure, and peripheral blood glucose of the patient, to obtain a test result; the first television display is configured to amplify content on the comprehensive information surveillance monitor for display; the movable low-field magnetic resonance imager is configured to perform magnetic resonance imaging (MRI) on a head and neck of the patient; the AI-assisted decision-making system is in communication connection with the comprehensive information surveillance monitor, the process support AI assistant, the test device, the first television display, and the movable low-field magnetic resonance imager separately; and the AI-assisted decision-making system is configured to assist in decision-making based on an automatic inquiry result, the scale score result, the test result, and MRI results of the head and neck, to generate and display a therapy regimen; and
a small refrigerator, a first aid medicine cabinet, and a storage cabinet are set in the thrombolytic therapy area, and configured to store medicines, reagents, and first aid medicines with different temperature requirements; an ambulance and a vital signs monitoring system are further set in the thrombolytic therapy area; the ambulance is configured to rescue the patient in medical emergency; and the vital signs monitoring system is configured to monitor and display the vital signs of the patient in real time;
wherein new-generation thrombolytic drugs and necessary medicines are provided in the thrombolytic therapy area, and a medication regimen is determined by pharmacogenetic testing; genotyping of genes of CYP2C19, CYP2C9, and VKORC are determined by a non-invasive rapid genotyping tester; and results are automatically transmitted to the AI-assisted decision-making system, effectiveness and safety of various types of drugs for the patient are preliminary determined based on genotyping of key genes for drug metabolism, and therapy suggestions are given.
|